X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2023/10/10/2757386/0/en/Helsinn-closes-financing-agreement-with-BancaStato-to-support-business-objectives-and-growth.html
https://www.globenewswire.com/news-release/2023/06/12/2686333/0/en/Helsinn-announces-publication-of-data-evaluating-impact-of-AKYNZEO-fosnetupitant-palonosetron-on-treatment-outcomes-and-healthcare-costs.html
https://www.globenewswire.com/news-release/2023/02/03/2601287/0/en/Helsinn-announces-publication-of-new-data-evaluating-impact-of-NEPA-netupitant-palonosetron-on-hospital-costs.html
https://www.globenewswire.com/news-release/2023/01/10/2586068/0/en/Helsinn-closes-financing-agreement-with-Oberland-Capital.html
https://www.globenewswire.com/news-release/2023/01/09/2585134/0/en/Helsinn-announces-the-appointment-of-Dr-Melanie-Rolli-as-Group-Chief-Executive-Officer.html
https://www.globenewswire.com/news-release/2022/10/18/2536307/0/en/Helsinn-publishes-new-data-evaluating-chlormethine-gel-s-mode-of-action-in-Dermatology-and-Therapy.html
https://www.fiercepharma.com/pharma/bridgebios-cancer-drug-truseltiqs-future-unclear-partner-helsinn-withdrawing-nda
https://www.globenewswire.com/news-release/2022/08/08/2493553/0/en/Helsinn-presents-newly-available-data-on-vepafestinib-at-IASLC-2022-World-Conference-on-Lung-Cancer.html
https://www.globenewswire.com/news-release/2022/06/02/2455231/0/en/New-data-on-Helsinn-s-oncology-pipeline-presented-at-American-Society-of-Clinical-Oncology-ASCO-Annual-Meeting-2022.html
https://www.globenewswire.com/news-release/2022/05/25/2450326/0/en/Helsinn-Establishes-New-R-D-Hub-in-the-U-S-to-Support-its-Global-Fully-Integrated-Targeted-Therapy-FITT-Strategy.html
Market Place
Share 
